NimodipineThird Party Manufacturing in India

Nimodipine works by inhibiting the influx of extracellular calcium ions through L-type voltage-gated calcium channels.

It has a high lipophilicity, which allows it to cross the blood-brain barrier easily and exert a selective effect on cerebral blood vessels. This cerebral vasodilation helps the body prevent or relieve cerebral vasospasm following subarachnoid hemorrhage.

Unlike other calcium channel blockers, Nimodipine has a greater effect on cerebral arteries than on peripheral vessels. It is highly effective for patients recovering from subarachnoid hemorrhage to prevent ischemic neurologic deficits.

Therapeutic Uses

Nimodipine is prescribed for the treatment of:

• Subarachnoid Hemorrhage (SAH): Improvement of neurological outcome by reducing the incidence and severity of ischemic deficits in patients with SAH from ruptured intracranial aneurysms.

Why Manufacturers Choose Nimodipine

Nimodipine is an essential critical care medication used extensively in neurology and intensive care units globally. The specialized manufacturing requirement for its stable intravenous formulation creates a high barrier to entry, making quality suppliers highly valued.

This makes Nimodipine one of the most sought-after molecules for third party manufacturing in India, particularly for hospital supply and export-oriented companies.